---
title: "Candel Therapeutics (CADL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CADL.US/norm.md"
symbol: "CADL.US"
name: "Candel Therapeutics"
parent: "https://longbridge.com/en/quote/CADL.US.md"
datetime: "2026-05-20T20:44:54.264Z"
locales:
  - [en](https://longbridge.com/en/quote/CADL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CADL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CADL.US/norm.md)
---

# Candel Therapeutics (CADL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1421 | -0.5373 | -0.2053 | -0.0931 | 0.1300 |
| ROE | -37.32% | -178.70% | -52.93% | -23.27% | 41.87% |
| Revenue | - | - | - | - | - |
| Net income | -8.86M | -29.50M | -11.27M | -4.80M | 7.38M |
| Operating income | -16.28M | -15.74M | -13.21M | -11.18M | -8.13M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 201.92M | 125.19M | 93.60M | 105.97M | 95.91M |
| Leverage | 1.46 | 2.41 | 1.17 | 1.17 | 1.28 |
| BVPS | 1.88 | 0.9458 | 1.46 | 1.64 | 1.52 |
| Turnover | - | - | - | - | - |
| Cash & STI | 194.83M | 119.73M | 86.96M | 100.69M | 92.17M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.64M | 3.30M | 3.11M | 2.05M | 2.43M |
| Net debt | -145.56M | -70.70M | -79.76M | -92.35M | -81.25M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -18.04M | -10.57M | -10.24M | -8.89M | -8.62M |
| Investing CF | -675000.00 | -409000.00 | -117000.00 | -31000.00 | -3000.00 |
| Financing CF | 93.81M | 43.90M | -3.37M | 17.44M | -1.87M |
| Free CF | -12.47M | -5.00M | -8.44M | -10.56M | -21.11M |
| OCF coverage | -2672.15% | -227.66% | -387.14% | -351.28% | -344.23% |
| Repaid & issued | - | 47.95M | - | - | - |
| CapEx | -675000.00 | -409000.00 | -144000.00 | -31000.00 | -3000.00 |